Additionally, CD14+ CD16+ monocyte absolute count and CD14+ CD16+ monocyte %monocyte may reduce the risk of RA, whereas CD20 on IgD+ CD38^dim B cells may increase it. This evidence concerns the gene CD38 and rheumatoid arthritis.